Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

3

Oct 2025

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Down syndrome is associated with accelerated aging. It is estimated that up to 90% of individuals with the condition develop Alzheimer's disease before the age of 70. A study by researchers at the University of São Paulo (USP) in Brazil identified high levels of neuroinflammation in young individuals with Down syndrome, an additional factor explaining the high prevalence of Alzheimer's disease in older people with the condition. The discovery paves the way for strategies to prevent and monitor the disease.

Exploring exercise's physiological response to fight diabetes

3

Oct 2025

Exploring exercise's physiological response to fight diabetes

Don't love the gym? Neither does exercise scientist Ryan Montalvo. But he goes anyway.<br /><br />While any workout can seem daunting, the physical stress of exercise often affords long-term benefits. One advantage is that it triggers a physiological response that allows our cells to adjust to meet future energy demand in what's known as a hormetic response.

New tool enables and enhances protein investigations

3

Oct 2025

New tool enables and enhances protein investigations

A new tool greatly improves scientists' ability to identify and study proteins that regulate gene activity in cells, according to research led by Weill Cornell Medicine investigators. The technology should enable and enhance investigations in both fundamental biology and disease research.

Exciting sustainability milestone at Evotec Verona

3

Oct 2025

Exciting sustainability milestone at Evotec Verona

Following our update on the heat pump installation at our site in Verona, Italy, we are proud to share that GSE (Gestore dei Servizi Energetici – the Italian Energy Services Operator) has officially approved our annual energy savings report for Italy, awarding us 301 Energy Efficiency Certificates (TEE) per year!

New algae gel provides realistic platform for breast cancer research

3

Oct 2025

New algae gel provides realistic platform for breast cancer research

In 2020, right when Jane Baude was starting her Ph.D. research at UC Santa Barbara, she learned that a critical component of her experiment - the gel needed to grow and test mammary epithelial cells - wouldn't be available for nearly a year because of pandemic-related production issues. So, she and her adviser, professor Ryan Stowers, decided to pivot: Baude would engineer her own gel to study cells.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.